# Chronic Urticaria - Long Term Assessment of Effects of Rupatadine

> **NCT02358265** · PHASE3 · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 192 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

- **DRUG:** 10 mg Rupatadine on demand
- **DRUG:** 10 mg Rupatadine
- **DRUG:** 20 mg Rupatadine
- **DRUG:** 10 mg Rupatadine on demand (sham updosing to 20 mg)

## Key facts

- **NCT ID:** NCT02358265
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2017-11-20
- **Final completion:** 2018-06-15
- **Target enrollment:** 192 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358265, "Chronic Urticaria - Long Term Assessment of Effects of Rupatadine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02358265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*